Discontinuation report NOVOLIN GE 40/60 PENFILL
| Report ID | 168714 |
| Drug Identification Number | 02024314 |
| Brand name | NOVOLIN GE 40/60 PENFILL |
| Common or Proper name | NOVOLIN GE 40/60 PENFILL |
| Company Name | NOVO NORDISK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | INSULIN ISOPHANE HUMAN BIOSYNTHETIC INSULIN INJECTION HUMAN BIOSYNTHETIC |
| Strength(s) | 60UNIT 40UNIT |
| Dosage form(s) | SUSPENSION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | EA |
| ATC code | A10AD |
| ATC description | INSULINS AND ANALOGUES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2023-03-31 |
| Actual discontinuation date | |
| Remaining supply date | 2023-03-31 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Supply to wholesalers estimated to last until March 2023 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
| Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2022-09-07 | French | Compare |
| v2 | 2022-09-07 | French | Compare |
| v1 | 2022-09-07 | English | Compare |
Showing 1 to 3 of 3